NO992477L - Sugetablett med modifisert frigj°ring av virkestoffer i gastrointestinalsystemet - Google Patents

Sugetablett med modifisert frigj°ring av virkestoffer i gastrointestinalsystemet

Info

Publication number
NO992477L
NO992477L NO992477A NO992477A NO992477L NO 992477 L NO992477 L NO 992477L NO 992477 A NO992477 A NO 992477A NO 992477 A NO992477 A NO 992477A NO 992477 L NO992477 L NO 992477L
Authority
NO
Norway
Prior art keywords
modified release
active substances
release
gastrointestinal system
suction tablet
Prior art date
Application number
NO992477A
Other languages
English (en)
Other versions
NO992477D0 (no
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO992477D0 publication Critical patent/NO992477D0/no
Publication of NO992477L publication Critical patent/NO992477L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Det blir beskrevet en farmasøytisk sugetablett med virkestoffholdige partikler for modifisert frigjøring av virkestoffer i gastrointestinal systemet, hvilken tablett har en første frigjøringskontrollerende omhylling, og en andre, ytre omhylling med spyttresistente egenskaper. Den første omhyllingen som kontrollerer virkestoff- frigjøringen kan ha retarderende eller magesaftresistente egenskaper.
NO992477A 1996-11-23 1999-05-21 Sugetablett med modifisert frigj°ring av virkestoffer i gastrointestinalsystemet NO992477L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19648576A DE19648576C2 (de) 1996-11-23 1996-11-23 Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
PCT/EP1997/006395 WO1998023262A2 (de) 1996-11-23 1997-11-17 Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt

Publications (2)

Publication Number Publication Date
NO992477D0 NO992477D0 (no) 1999-05-21
NO992477L true NO992477L (no) 1999-05-21

Family

ID=7812582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992477A NO992477L (no) 1996-11-23 1999-05-21 Sugetablett med modifisert frigj°ring av virkestoffer i gastrointestinalsystemet

Country Status (11)

Country Link
US (1) US6270798B2 (no)
EP (1) EP0941070B1 (no)
JP (1) JP2001527526A (no)
KR (1) KR100429489B1 (no)
AT (1) ATE235232T1 (no)
AU (1) AU725493B2 (no)
CA (1) CA2272442C (no)
DE (2) DE19648576C2 (no)
ES (1) ES2196381T3 (no)
NO (1) NO992477L (no)
WO (1) WO1998023262A2 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
US20060251722A1 (en) * 2005-05-03 2006-11-09 Novavax, Inc. Multi-component vitamin and mineral supplement for the optimal absorption of components
US9284307B2 (en) 2009-08-05 2016-03-15 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
SG181797A1 (en) 2009-12-18 2012-07-30 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
US20110183032A1 (en) * 2010-01-15 2011-07-28 Kemin Industries, Inc. Stomach-proected Alpha-amylase to Improve the Utilization of Diet Energy and Growth Performance of Animals
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
EP2611792B1 (en) 2010-09-01 2017-02-01 Ambit Biosciences Corporation Hydrobromide salts of a pyrazolylaminoquinazoline
US8912324B2 (en) 2010-09-01 2014-12-16 Ambit Biosciences Corporation Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
JP2014503597A (ja) 2011-01-31 2014-02-13 セルジーン コーポレイション シチジンアナログの医薬組成物及びその使用方法
US9353100B2 (en) 2011-02-10 2016-05-31 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
TW201341367A (zh) 2012-03-16 2013-10-16 Axikin Pharmaceuticals Inc ３，５－二胺基吡唑激酶抑制劑
ES2652266T3 (es) * 2012-04-02 2018-02-01 Pharma Seeds Create, Llc Composición sólida de dosificación oral de ibuprofeno que comprende un copolímero de ácido metacrílico
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
WO2015042375A1 (en) 2013-09-20 2015-03-26 Idenix Pharmaceuticals, Inc. Hepatitis c virus inhibitors
US20150174079A1 (en) * 2013-12-24 2015-06-25 Food for Health International, LLC Lozenges with silver nanoparticles
US20170066779A1 (en) 2014-03-05 2017-03-09 Idenix Pharmaceuticals Llc Solid forms of a flaviviridae virus inhibitor compound and salts thereof
CA3175724C (en) 2014-03-20 2024-01-09 Capella Therapeutics, Inc. Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof
TWI705967B (zh) 2014-03-20 2020-10-01 美商卡佩拉醫療公司 苯并咪唑衍生物及其醫藥組合物及使用方法
HUE049801T2 (hu) 2014-12-23 2020-10-28 Sma Therapeutics Inc 3,5-diaminopirazol kináz inhibitorok

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565107B1 (fr) 1984-05-30 1986-09-05 Ucb Laboratoires Nouveau medicament a base de charbon actif et son procede de preparation
EP0212745B1 (en) 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
JP2573969B2 (ja) * 1987-10-21 1997-01-22 帝國製薬株式会社 薬物断続放出性口腔内適用製剤
IT1256651B (it) 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
AU639988B2 (en) * 1990-04-11 1993-08-12 Pharmacia & Upjohn Company Taste masking of ibuprofen by fluid bed coating
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
ATE217789T1 (de) * 1992-06-04 2002-06-15 Smithkline Beecham Corp Angenehm schmeckende pharmazeutische zusammensetzungen
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung

Also Published As

Publication number Publication date
WO1998023262A3 (de) 1998-09-11
ATE235232T1 (de) 2003-04-15
CA2272442A1 (en) 1998-06-04
AU725493B2 (en) 2000-10-12
EP0941070A2 (de) 1999-09-15
JP2001527526A (ja) 2001-12-25
US20010001668A1 (en) 2001-05-24
DE59709645D1 (de) 2003-04-30
ES2196381T3 (es) 2003-12-16
CA2272442C (en) 2004-05-11
WO1998023262A2 (de) 1998-06-04
KR100429489B1 (ko) 2004-05-03
AU5322598A (en) 1998-06-22
DE19648576C2 (de) 1999-08-12
DE19648576A1 (de) 1998-06-04
US6270798B2 (en) 2001-08-07
NO992477D0 (no) 1999-05-21
KR20000057205A (ko) 2000-09-15
EP0941070B1 (de) 2003-03-26

Similar Documents

Publication Publication Date Title
NO992477D0 (no) Sugetablett med modifisert frigj°ring av virkestoffer i gastrointestinalsystemet
BG104620A (en) Oral pharmaceutical extended release dosage form
AU7031500A (en) Therapeutic quinazoline compounds
MY133883A (en) Gastrointestinal drug delivery system
PL341055A1 (en) Novel form of a drug for oral administration of active compounds being unstable in acid environments
MX9804008A (es) Formulaciones farmaceuticas.
DK0750494T3 (da) Hydrofobe lægemiddelafgivelsessystemer
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
TR200200966T1 (tr) Tüberkülöz ilaçlarının yeni farmasötik terkipleri ve hazırlanma prosesleri
NO992907D0 (no) Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
WO2001008688A3 (en) Beta-carboline drug products
CA2275763A1 (en) Combatting infection in delivery systems
BR9815248A (pt) Sistema monolìtico contendo um ou mais medicamentos, consistindo de três camadas com diferentes mecanismos de liberação
MY118569A (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
SE9201930D0 (sv) Gastric antibacterial treatment
HK126193A (en) Drug particles having constant release
ATE149827T1 (de) Feste arzneimitteldosierungsform und methode zur verminderung des abriebs
AU4519399A (en) Anti-inflammatory pharmaceutical formulations
AP2001002233A0 (en) Particulate composition of eletriptan
GEP20063719B (en) Prevention of Migraine Recurrence
ATE213416T1 (de) Arzneizubereitungen enthaltend cefuroxim axetil
CA2243863A1 (en) Gastrointestinal drug delivery system
AU4930300A (en) Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
SI1077703T1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application